AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
N-BUTYLHYOSCINE BROMURE
9 registrations across 1 African market— 0 active
Markets with N-BUTYLHYOSCINE BROMURE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| BUSCOPAN Comprime enrobé / 10 MG | 🇹🇳Tunisia | SIPHAT | expired | Jul 2012 |
| SPASMOPAN Solution injectable / 20 MG | 🇹🇳Tunisia | APM | expired | Apr 2002 |
| BUSCOPAN Solution injectable / 20 MG | 🇹🇳Tunisia | SIPHAT | expired | Dec 1994 |
| BUSCOPAN Comprimé / 10 MG | 🇹🇳Tunisia | SIPHAT | expired | Dec 1994 |
| BUSCOPAN Suppositoire / 10 MG | 🇹🇳Tunisia | SIPHAT | expired | Nov 1994 |
| BUSCOPAN Comprime enrobé / 10 MG | 🇹🇳Tunisia | SIPHAT | expired | Jun 1993 |
| BUSCOPAN Solution injectable / 20 MG | 🇹🇳Tunisia | SIPHAT | expired | Dec 1992 |
| BUSCOPAN Suppositoire / 10 MG | 🇹🇳Tunisia | SIPHAT | expired | Dec 1992 |
| SPASMOPAN Solution injectable / 20 MG | 🇹🇳Tunisia | APM | expired | Jan 1991 |
N-BUTYLHYOSCINE BROMURE in Africa — Regulatory Overview
N-BUTYLHYOSCINE BROMURE is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 0 (0%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.